BIOS FUND I, LP 13D and 13G filings for Actuate Therapeutics Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-30 12:08 pm Purchase | 2025-06-27 | 13D | Actuate Therapeutics Inc ACTU | BIOS FUND I, LP | 10,267,232 49.800% | 157,856 (+1.56%) | Filing |
| 2025-05-27 4:15 pm Sale | 2025-05-22 | 13D | Actuate Therapeutics Inc ACTU | BIOS FUND I, LP | 10,109,376 52.400% | -16,112 (-0.16%) | Filing |
| 2024-08-19 8:59 pm Purchase | 2024-08-14 | 13D | Actuate Therapeutics Inc ACTU | BIOS FUND I, LP | 10,125,488 52.800% | 10,125,488 (New Position) | Filing |